Canada's first case of a multidrug-resistant Corynebacterium diphtheriae strain, isolated from a skin abscess

J Clin Microbiol. 2011 Nov;49(11):4003-5. doi: 10.1128/JCM.05296-11. Epub 2011 Aug 31.

Abstract

A toxigenic Corynebacterium diphtheriae biovar mitis sequence type 136 (ST136) strain was recovered from a toe infection of an unvaccinated patient recently returned from India. The isolate was resistant to clindamycin, erythromycin (ermX positive), tetracycline, and trimethoprim-sulfamethoxazole, intermediate to ceftriaxone and cefotaxime, and had high MICs for telithromycin and chloramphenicol but was sensitive to other drugs.

Publication types

  • Case Reports

MeSH terms

  • Abscess / diagnosis*
  • Abscess / microbiology
  • Abscess / pathology
  • Adult
  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Typing Techniques
  • Canada
  • Corynebacterium diphtheriae / drug effects*
  • Corynebacterium diphtheriae / isolation & purification
  • Diphtheria / diagnosis
  • Diphtheria / microbiology
  • Diphtheria / pathology
  • Drug Resistance, Multiple, Bacterial*
  • Humans
  • India
  • Male
  • Molecular Typing
  • Skin Diseases, Bacterial / diagnosis*
  • Skin Diseases, Bacterial / microbiology
  • Skin Diseases, Bacterial / pathology
  • Toes / microbiology
  • Travel

Substances

  • Anti-Bacterial Agents